MIP-Based Optical Sensors: Exploring Principles and Applications as Artificial Antibodies in Disease Detection and Monitoring

This chapter delves into the rapidly emerging field of molecularly imprinted polymers (MIPs) integrated into optical sensors, exploring their remarkable applications as artificial antibodies for disease detection and monitoring. We embark on the journey by elucidating the fundamental principles of optical sensors, emphasizing their unique ability to detect and quantify analytes through optical signals, including absorption, fluorescence, or refractive index changes. Unveiling the versatility of MIP synthesis and molecular imprinting, we underscore the exceptional selectivity of these synthetic receptors in recognizing target molecules. Presenting a compelling alternative to traditional antibodies and aptamers, MIPs exhibit enhanced stability, cost-effectiveness, and nonimmunogenicity, positioning them as promising candidates in disease diagnostics. The chapter further emphasizes the seamless integration of MIPs with optical transduction, where binding events between MIPs and targets induce measurable changes in light properties. The potential of MIP-based optical sensors for highly sensitive and real-time disease biomarker detection is explored, encompassing various medical conditions, from cancer to infectious diseases and autoimmune disorders. Through several illuminating case studies, we showcase the remarkable performance of MIP-based optical sensors in disease monitoring. Demonstrating their ability to detect disease-specific biomolecules and pathogens with exceptional specificity, MIPs pave the way for early diagnosis, personalized treatment, and improved patient outcomes. In addressing challenges and prospects in this exciting field, we delve into factors influencing sensor sensitivity and selectivity while highlighting cutting-edge advancements in MIP nanotechnology. Moreover, the chapter explores the potential synergy of MIP-based optical sensors with advanced imaging techniques, opening up new vistas for integrated diagnostic and therapeutic approaches. In conclusion, MIP-based optical sensors represent a promising frontier in disease detection and monitoring, harnessing the potential of artificial antibodies to revolutionize healthcare applications. As research progresses, these innovative biosensing platforms hold immense promise in reshaping medical diagnostics, propelling us toward a future of proactive and personalized healthcare.